| Mr Daniel Kane, MS | |
|
195 Ne Gilman Blvd Ste 100, Issaquah, WA 98027-2940 | |
| (425) 295-7697 | |
| Not Available |
| Full Name | Mr Daniel Kane |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 195 Ne Gilman Blvd Ste 100, Issaquah, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467006155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | MG60970327 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Daniel Kane, MS 195 Ne Gilman Blvd Ste 100, Issaquah, WA 98027-2940 Ph: (425) 295-7697 | Mr Daniel Kane, MS 195 Ne Gilman Blvd Ste 100, Issaquah, WA 98027-2940 Ph: (425) 295-7697 |
News Archive
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating chronic obstructive pulmonary disease (COPD) on ex vivo 3D human lung tissue cultures (3D-LTCs). The results have now been published in the European Respiratory Journal.
Scientists at the Immunology Frontier Research Center at Osaka University, Japan have pinpointed a specific molecular events that could explain allergic reactions to air pollution.
Isis Pharmaceuticals, Inc. announced the initiation of two Phase 2 studies of ISIS-EIF4ERx in patients with non-small cell lung cancer and prostate cancer. These studies are part of Isis' broad Phase 2 development program designed to evaluate ISIS-EIF4ERx in multiple types of cancer. ISIS-EIF4ERx targets eukaryotic initiation factor-4E (eIF-4E), a traditionally "undruggable" target that is thought to promote tumor growth and metastasis in many cancers.
The first clinical trial in South Africa and on the continent for a Covid-19 vaccine was announced today, 23 June 2020, at a virtual press conference hosted by the University of the Witwatersrand, Johannesburg (Wits).
A new phase III cancer treatment trial has opened for patient enrollment that examines two treatments that work in completely different ways yet have both been shown in previous clinical trials to be effective in treating patients with advanced melanoma, the ECOG-ACRIN Cancer Research Group announced today.
› Verified 8 days ago
Ms. Paula L Anderson, MA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3707bprovidence Point Dr Se D, Issaquah, WA 98029 Phone: 425-606-7384 | |
Nichole Woods, MS, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 545 Rainier Blvd N, Issaquah, WA 98027 Phone: 503-741-9307 | |
Ms. Brandi Sue Defazio, MHA, MA, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 310 3rd Ave Ne Ste 118, Issaquah, WA 98027 Phone: 425-894-9676 | |
Nadene Reichert, MFT-A Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2520 Ne Mulberry Walk, Issaquah, WA 98029 Phone: 206-909-9728 | |
Nina Ellen Erichsen, LMFTA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3707 Providence Point Dr Se, Issaquah, WA 98029 Phone: 425-409-6414 Fax: 425-409-6618 | |
Debra Steinberg Kuntz, LMFTA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 55 1st Pl Nw, Issaquah, WA 98027 Phone: 425-445-2342 |